In a 35-year-old woman with no past medical history who presents with 45 minutes of palpitations and lightheadedness, a regular pulse of 170 beats per minute, blood pressure 115/68 mmHg, and an electrocardiogram showing narrow-complex tachycardia at 170 beats per minute, what is the appropriate first step in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vagal Maneuvers Are the Appropriate First Step

In this hemodynamically stable patient with regular narrow-complex tachycardia at 170 bpm, vagal maneuvers should be performed immediately as the first-line intervention. 1

Clinical Reasoning

This 35-year-old woman presents with a classic presentation of supraventricular tachycardia (SVT), most likely atrioventricular nodal reentrant tachycardia (AVNRT), which is the most common SVT and occurs predominantly in young women without structural heart disease 1. Her hemodynamic stability (BP 115/68 mmHg, though symptomatic with lightheadedness) allows for a stepwise approach rather than immediate cardioversion.

Stepwise Management Algorithm

Step 1: Vagal Maneuvers (Perform Immediately)

The 2015 ACC/AHA/HRS guidelines give vagal maneuvers a Class I, Level B-R recommendation as first-line therapy 1. These should be performed with the patient in the supine position:

  • Valsalva maneuver: Have the patient bear down against a closed glottis for 10-30 seconds, generating at least 30-40 mmHg of intrathoracic pressure 1
  • Carotid sinus massage: After confirming absence of carotid bruit by auscultation, apply steady pressure over the right or left carotid sinus for 5-10 seconds 1
  • Modified diving reflex: Apply an ice-cold, wet towel to the face 1

Important caveat: Valsalva is more successful than carotid massage, and switching between techniques achieves an overall success rate of 27.7% 1. If one fails, try another.

Step 2: Adenosine (If Vagal Maneuvers Fail)

If vagal maneuvers are unsuccessful, adenosine receives a Class I, Level B-R recommendation 1. Adenosine terminates AVNRT in approximately 95% of patients and serves both therapeutic and diagnostic purposes by unmasking atrial activity if the rhythm is atrial flutter or atrial tachycardia rather than AVNRT 1.

Step 3: Alternative Pharmacologic Therapy

If adenosine fails or is contraindicated, intravenous calcium channel blockers (diltiazem or verapamil) or beta-blockers are reasonable alternatives (Class IIa, Level B-R) 1.

Critical safety warning: Ensure this is NOT ventricular tachycardia or pre-excited atrial fibrillation before giving calcium channel blockers, as these patients may develop ventricular fibrillation 1. The narrow-complex morphology and regular rhythm at 170 bpm make VT unlikely, but pre-excitation should be considered.

Step 4: Synchronized Cardioversion

Reserved for patients who remain hemodynamically unstable or when pharmacologic therapy fails or is contraindicated (Class I, Level B-NR) 1.

Why Not Start with Adenosine?

While adenosine has a 95% success rate 1, vagal maneuvers are:

  • Immediately available without IV access
  • Free of medication side effects
  • Quick to perform (takes seconds)
  • Guideline-recommended as first-line therapy
  • Can be successful in up to 27.7% of cases when multiple techniques are tried 1

The sequential approach (vagal maneuvers → adenosine → other medications → cardioversion) maximizes the chance of conversion while minimizing interventions and side effects in this stable patient.

Related Questions

What is the appropriate management for a patient with a narrow-complex tachycardia that shows distinct P waves?
In a 78-year-old heavy‑goods driver with Holter monitoring showing 124 episodes of narrow‑complex tachycardia up to 207 bpm but no symptoms, how should the condition be managed and what are the implications for his commercial driving eligibility?
In a 29-year-old female with shortness of breath and a narrow‑complex tachycardia on ECG who is hemodynamically stable (normotensive, normal respiratory rate, normothermic, oxygen saturation 95% on room air), what is the first‑line medication?
What is the appropriate initial management for a 49-year-old woman with symptomatic supraventricular tachycardia (31 episodes, longest 2 minutes, maximum heart rate 130 bpm) identified on a 24‑hour Holter monitor?
What is the clinical significance of a resting heart rate of 53 beats per minute and a respiratory rate of 27 breaths per minute in a 40‑year‑old woman?
What oral antibiotic regimen and dosage should be used for an adult with an E. coli‑positive wound culture?
How long should leflunomide be held before and after coronary artery bypass graft (CABG) surgery?
What are the clinically important differences between Klebsiella oxytoca and Klebsiella pneumoniae infections?
When should follow-up visits and blood pressure monitoring be performed after initiating hormonal contraception?
What is the recommended treatment for a nondisplaced comminuted intra‑articular fracture of the proximal tibia involving the lateral tibial plateau?
Do drug holidays reduce tolerance to stimulant medications (e.g., methylphenidate, dexmethylphenidate, mixed amphetamine salts, lisdexamfetamine) and restore their efficacy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.